GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
Source | Last Updated |
---|---|
GlycoNAVI Proteins | December 11, 2024 |
PDB ID | UniProt ID | Title ▲ | Descriptor |
---|---|---|---|
5KUY | 5KUY | Influenza hemagglutinin H3 A/Hong Kong/1/1968 in complex with designed inhibitor protein HSB.2A | |
3UBQ | C3W5S1 | Influenza hemagglutinin from the 2009 pandemic in complex with ligand 3SLN | |
3UBN | C3W5S1 | Influenza hemagglutinin from the 2009 pandemic in complex with ligand 6SLN | |
3UBJ | C3W5S1 | Influenza hemagglutinin from the 2009 pandemic in complex with ligand LSTa | |
3UBE | C3W5S1 | Influenza hemagglutinin from the 2009 pandemic in complex with ligand LSTc | |
4HKX | 4HKX | Influenza hemagglutinin in complex with CH67 Fab | |
4HKX | A7UPX0 | Influenza hemagglutinin in complex with CH67 Fab | |
5UGY | A7UPX0 | Influenza hemagglutinin in complex with a neutralizing antibody | |
5UGY | S6C4S0 | Influenza hemagglutinin in complex with a neutralizing antibody | |
5UGY | 5UGY | Influenza hemagglutinin in complex with a neutralizing antibody | |
5UGY | S6C4S0 | Influenza hemagglutinin in complex with a neutralizing antibody | |
5UGY | 5UGY | Influenza hemagglutinin in complex with a neutralizing antibody | |
5UGY | Q8N355 | Influenza hemagglutinin in complex with a neutralizing antibody | |
5UGY | Q8N355 | Influenza hemagglutinin in complex with a neutralizing antibody | |
4KS1 | Q0A480 | Influenza neuraminidase in complex with antiviral compound (3S,4R,5R)-4-(acetylamino)-3-amino-5-(pentan-3-yloxy)cyclohex-1-ene-1-carboxylic acid | |
2IBX | Q6DQ34 | Influenza virus (VN1194) H5 HA | |
3W09 | P03472 | Influenza virus neuraminidase subtype N9 (TERN) complexed with 2,3-dif guanidino-neu5ac2en inhibitor | |
2YL8 | P49610 | Inhibition of the pneumococcal virulence factor StrH and molecular insights into N-glycan recognition and hydrolysis | |
1R4L | Q9BYF1 | Inhibitor Bound Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2) | |
1R4L | 1R4L | Inhibitor Bound Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2) | |
7NEU | Q96IY4 | Inhibitor Complex with Thrombin Activatable Fibrinolysis Inhibitor (TAFIa) | |
2PGB | P00734 | Inhibitor-free human thrombin mutant C191A-C220A | |
7AUW | Q16820 | Inhibitory complex of human meprin beta with mouse fetuin-B. | |
7AUW | Q9QXC1 | Inhibitory complex of human meprin beta with mouse fetuin-B. | |
8GYO | Q96RD7 | Inner channel lipids regulated gating mechanism of human pannexins. | |
5ZNS | H9J9M0 | Insect chitin deacetylase | |
5ZNT | H9J9M0 | Insect chitin deacetylase | |
1S78 | P04626 | Insights into ErbB signaling from the structure of the ErbB2-pertuzumab complex | |
1S78 | 1S78 | Insights into ErbB signaling from the structure of the ErbB2-pertuzumab complex | |
4DCH | P35557 | Insights into Glucokinase Activation Mechanism: Observation of Multiple Distinct Protein Conformations | |
5FQL | P22304 | Insights into Hunter syndrome from the structure of iduronate-2- sulfatase | IDURONATE-2-SULFATASE (E.C.3.1.6.13) |
7KD6 | 7KD6 | Insulin Receptor L1-CR plus alphaCT fragment in co-complex with Fv 83-7 and single-chain insulin SCI-b | |
7KD6 | P06213 | Insulin Receptor L1-CR plus alphaCT fragment in co-complex with Fv 83-7 and single-chain insulin SCI-b | |
6CE9 | P06213 | Insulin Receptor ectodomain in complex with two insulin molecules | |
6CE9 | P01308 | Insulin Receptor ectodomain in complex with two insulin molecules | |
6CE9 | P01318 | Insulin Receptor ectodomain in complex with two insulin molecules | |
6CEB | P06213 | Insulin Receptor ectodomain in complex with two insulin molecules - C1 symmetry | |
6CEB | P01308 | Insulin Receptor ectodomain in complex with two insulin molecules - C1 symmetry | |
6CEB | P01318 | Insulin Receptor ectodomain in complex with two insulin molecules - C1 symmetry | |
4OGA | P01308 | Insulin in complex with Site 1 of the human insulin receptor | |
4OGA | 4OGA | Insulin in complex with Site 1 of the human insulin receptor | |
4OGA | P06213 | Insulin in complex with Site 1 of the human insulin receptor | |
2HR7 | P06213 | Insulin receptor (domains 1-3) | |
5KQV | P01317 | Insulin receptor ectodomain construct comprising domains L1,CR,L2, FnIII-1 and alphaCT peptide in complex with bovine insulin and FAB 83-14 (REVISED STRUCTURE) | |
5KQV | 5KQV | Insulin receptor ectodomain construct comprising domains L1,CR,L2, FnIII-1 and alphaCT peptide in complex with bovine insulin and FAB 83-14 (REVISED STRUCTURE) | |
5KQV | P06213 | Insulin receptor ectodomain construct comprising domains L1,CR,L2, FnIII-1 and alphaCT peptide in complex with bovine insulin and FAB 83-14 (REVISED STRUCTURE) | |
3W12 | P01308 | Insulin receptor ectodomain construct comprising domains L1-CR in complex with high-affinity insulin analogue [D-PRO-B26]-DTI-NH2, alpha-CT peptide(704-719) and FAB 83-7 | |
3W12 | 3W12 | Insulin receptor ectodomain construct comprising domains L1-CR in complex with high-affinity insulin analogue [D-PRO-B26]-DTI-NH2, alpha-CT peptide(704-719) and FAB 83-7 | |
3W12 | P06213 | Insulin receptor ectodomain construct comprising domains L1-CR in complex with high-affinity insulin analogue [D-PRO-B26]-DTI-NH2, alpha-CT peptide(704-719) and FAB 83-7 | |
3W13 | P01308 | Insulin receptor ectodomain construct comprising domains L1-CR in complex with high-affinity insulin analogue [D-PRO-B26]-DTI-NH2, alphact peptide(693-719) and FAB 83-7 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.1.0
Last updated: December 9, 2024